slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 69,031-69,060
Pages 3,679
Rows per page 30
Component
69,031-69,060 of 110,355
23
Includes both longitudinal efficacy data (line chart) and pharmacokinetic data (bar charts) comparing plasma vs liver concentrations.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
24
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
27
The slide uses a table to present a timeline of clinical milestones.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
19
The slide uses a dual-section layout to separate commercial regulatory events from clinical trial data readouts and study initiations.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations 1 hit
07
The slide highlights a total full-year revenue of $401M in the first year of launch.argenx SE | Results Presentation Deck | 11 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
27
Includes specific footnotes regarding non-cash impairment charges and exchange rate calculations.Arrival | Results Presentation Deck | 28 slides · Arrival
Conference presentation Investor relations Beat · Action1 hit
12
The slide features a photograph of the engine in a vacuum chamber test.Astra | Results Presentation Deck | 19 slides · Astra
Conference presentation Investor relations Beat · Solution1 hit
14
The slide uses a dark theme with bar charts to show quarter-over-quarter performance.Astra | Results Presentation Deck | 19 slides · Astra
Conference presentation Investor relations Beat · Financials1 hit
15
The slide uses a 2x2 grid layout to present financial performance indicators.Astra | Results Presentation Deck | 19 slides · Astra
Conference presentation Investor relations Beat · Financials1 hit
06
The slide uses a three-column layout to categorize sustainability metrics, with a sidebar for general strategy progress.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
09
Includes a map of global forest commitments and specific metrics for reforestation and water footprint reduction.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
10
Slide 10 of a presentation; includes footnotes explaining SET/SET-1 and specific targets.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
02
Includes a date note at the bottom left: 'Note: Unless otherwise stated, this presentation is as of March 2nd, 2023'ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
Numbered list format used to summarize key company pillars.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
04
Uses a hierarchical structure to break down the objective into three strategic pillars.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a Gantt-style visualization to show the progress of drug development programs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
06
The slide uses a timeline framework to show past achievements and future milestones.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · RoadmapLoop · Why Now1 hit
08
The slide uses a vertical timeline-like structure to highlight the 'Huge Need for Development' and a map/metric section for global impact.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
10
The slide uses a vertical process flow to demonstrate the progression of clinical validation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
12
The slide highlights that low doses (40 or 80 mg TID) of RL-007 show superior cognitive performance compared to higher doses and Pregabalin.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
13
The slide uses a standard clinical trial flow diagram to illustrate the study protocol.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
16
The slide uses a line chart to show MADRS score changes over 12 weeks, highlighting the 25mg dose efficacy.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a split layout: a dark sidebar for product specs and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
21
The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a split-layout with a left-hand sidebar for product specs and a right-hand main area for clinical evidence and trial design.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
23
The slide uses a numbered list to highlight key safety findings alongside a detailed data table.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
24
The slide uses topographical brain maps to visualize EEG data changes.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit